Results 301 to 310 of about 160,832 (337)

Gemcitabine

Reactions Weekly, 2010
openaire   +2 more sources

The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

Nature Medicine, 2023
Yuan Wei, Yu-Pei Chen, Jiayi Shen
exaly  

Gemcitabine

Reactions Weekly, 2013
openaire   +2 more sources

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine, 2023
Matthew D Galsky, Sudeh Izadmehr, Edgar Ernesto Gonzalez Kozlova   +2 more
exaly  

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

Signal Transduction and Targeted Therapy, 2023
Hong-Hong Yan, Ying Cheng
exaly  

Gemcitabine

Reactions Weekly, 1998
openaire   +1 more source

Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs

Drug Resistance Updates, 2023
Baomin Shi
exaly  

Gemcitabine

Reactions Weekly, 2008
openaire   +2 more sources

Gemcitabine

Reactions Weekly, 2014
  +4 more sources

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of Clinical Oncology, 2007
Steven Gallinger
exaly